Mobidiag Ltd. Company Profile

03:07 EDT 20th June 2019 | BioPortfolio

Mobidiag is a commercial stage, fast growing molecular diagnostics company whose affordable, widely applicable and robust technology makes the power of molecular diagnostics available to address the spread of antimicrobial resistance (AMR) by rapid detection of pathogens and their potential resistance to antibiotics. Through its Amplidiag® and Novodiag® solutions, Mobidiag offers a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases to laboratories of all sizes.

News Articles [23 Associated News Articles listed on BioPortfolio]

Autobio Forms $19 Million China IVD JV with Mobidiag and Invests $11.4 Million in the Company

Autobio Diagnostics, a Zhengzhou IVD company, will form a $19 million JV with Finland's Mobidiag to bring Mobidiag's Novodiag® platform to China. The platform offers assays for human infectious di...

Mobidiag forms joint venture with Chinese Dx firm

Mobidiag and Autobio Diagnostics have formed a joint venture called Automobi Molecular Diagnostics to commercialize Mobidiag' -More- 

Mobidiag signs deals for distribution of Amplidiag and Novodiagdiagnostic solutions

Mobidiag has signed exclusive agreements for the distribution of Amplidiag and Novodiag with Helix2 for Greece and Interlab INTERAUTOMATIKA UAB for Latvia and Lithuania. Mobidiag has also signed The ...

Autobio makes €10m equity investment in Mobidiag as part of previously signed JV agreement

As part of a joint venture penned in December 2018, Mobidiag Ltd. received a €10mm ($11.5mm) equity investment from Autobio Diagnostics Co. Ltd. The JV was created to commercialize the Novodiag plat...

EU OKs molecular test from Mobidiag

European regulators have granted Finnish firm Mobidiag CE mark approval for its multiplex qPCR- and microarray-based test tha -More- 

Mobidiag to expand distribution into Middle East, Europe

Mobidiag has signed two-year distribution deals with three firms to bring its Amplidiag and Novodiag diagnostics solutions in -More- 

Autobio, Mobidiag form JV in China

Mobidiag Ltd. and Autobio Diagnostics Co. Ltd. are creating a joint venture to commercialize the Novodiag platform in China.

Mobidiag Launches Automobi Joint Venture In China

Finnish diagnostics company Mobidiag has launched its new joint venture with partner Autobio Diagnostics called Automobi. </p>   

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Performances of a H. Pylori Stool PCR Test

Performance of a non-invasive test for the detection of Helicobacter pylori and its resistance to clarithromycin in stool by Real-Time PCR Amplidiag H. pylori + ClariR (Mobidiag).

Companies [3 Associated Companies listed on BioPortfolio]


Founded in the year 2000, Mobidiag is specialized in the molecular diagnostics of infectious diseases. The focus area of the company is primarily to develop high-quality content for DNA biochip-based ...

Mobidiag Ltd.

Mobidiag is a commercial stage, fast growing molecular diagnostics company whose affordable, widely applicable and robust technology makes the power of molecular diagnostics avail...

Mobidiag Ltd

More Information about "Mobidiag Ltd." on BioPortfolio

We have published hundreds of Mobidiag Ltd. news stories on BioPortfolio along with dozens of Mobidiag Ltd. Clinical Trials and PubMed Articles about Mobidiag Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mobidiag Ltd. Companies in our database. You can also find out about relevant Mobidiag Ltd. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record